Mori R, Triolo L, De Stefano V, Giusti B P, De Sole P, Leone G
Instituto di Clinica Medica, Università Cattolica, Roma, Italia.
Nephron. 1988;48(3):213-6. doi: 10.1159/000184914.
Plasma antithrombin III (AT III) levels were measured as antigen concentration (radial immunodiffusion) and as heparin cofactor (amidolytic method) in 9 patients on continuous ambulatory peritoneal dialysis (CAPD). The loss of albumin, proteins, AT III antigen and AT III functional activity was calculated from the peritoneal dialysate and the corresponding serum levels were measured. The same determinations were performed on serum and urinary samples from 9 patients with nephrotic syndrome. Mean plasma levels of AT III antigen and AT III heparin cofactor in CAPD patients were normal, whereas nephrotic patients showed a reduction in these values within a wide range. However, the loss of AT III antigen was similar in both groups and was strictly correlated to the loss of albumin. Most AT III in the peritoneal dialysate from CAPD patients was still active, whereas in nephrotic patients only 26% of the excreted AT III was functionally active. The difference in plasma AT III was functionally active. The difference in plasma AT III levels between these two groups, in spite of the roughly similar amounts recovered in the dialysate and in the urine, might be explained by an additional AT III loss in nephrotic patients due to renal metabolism.
对9例持续性非卧床腹膜透析(CAPD)患者测定了血浆抗凝血酶III(AT III)水平,包括抗原浓度(放射免疫扩散法)和作为肝素辅因子的活性(酰胺水解法)。根据腹膜透析液计算白蛋白、蛋白质、AT III抗原和AT III功能活性的丢失量,并测定相应的血清水平。对9例肾病综合征患者的血清和尿液样本进行了同样的测定。CAPD患者的血浆AT III抗原和AT III肝素辅因子平均水平正常,而肾病综合征患者这些值在很宽范围内降低。然而,两组中AT III抗原的丢失相似,且与白蛋白的丢失密切相关。CAPD患者腹膜透析液中的大多数AT III仍具有活性,而肾病综合征患者排泄出的AT III中只有26%具有功能活性。两组间血浆AT III功能活性存在差异。尽管透析液和尿液中回收的量大致相似,但这两组患者血浆AT III水平的差异可能是由于肾病综合征患者肾脏代谢导致额外的AT III丢失所致。